Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Vitiligo

Interventions

DRUG

Azathioprine

azathioprine 50mg twice daily will be given

DRUG

Tofacitinib

It is a janus kinase inhibitor

Trial Locations (1)

Lahore general.hospital, Lahore

All Listed Sponsors

lead

Lahore General Hospital

OTHER_GOV

NCT07044141 - Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo | Biotech Hunter | Biotech Hunter